
Sign up to save your podcasts
Or


In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, developed by Melanoma Institute Australia and freely available at melanomarisk.org.au, help clinicians tailor care and improve outcomes.
Our multidisciplinary experts provide practical guidance on using tools to predict sentinel node metastasis, recurrence risk and more. Through real-world case examples and expert insights, this episode offers valuable strategies for integrating personalised risk assessment into your practice.
This podcast is suitable for multidisciplinary specialists, primary care physicians and other healthcare professionals.
Resources:
Speakers:
Please note that this podcast was accurate at the time of recording (August 2025) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
MIA’s Education Program is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.
By Melanoma Institute Australia4.3
33 ratings
In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, developed by Melanoma Institute Australia and freely available at melanomarisk.org.au, help clinicians tailor care and improve outcomes.
Our multidisciplinary experts provide practical guidance on using tools to predict sentinel node metastasis, recurrence risk and more. Through real-world case examples and expert insights, this episode offers valuable strategies for integrating personalised risk assessment into your practice.
This podcast is suitable for multidisciplinary specialists, primary care physicians and other healthcare professionals.
Resources:
Speakers:
Please note that this podcast was accurate at the time of recording (August 2025) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
MIA’s Education Program is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.

929 Listeners

861 Listeners

662 Listeners

65 Listeners

20 Listeners

18 Listeners

8,855 Listeners

2,642 Listeners

7,980 Listeners

386 Listeners

238 Listeners

20,566 Listeners

24 Listeners

2,523 Listeners

8,479 Listeners